Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kara Gibson

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Ophthalmology Science|June 11, 2025
Effect of Faricimab versus Aflibercept on Hyperreflective Foci in Patients with Diabetic Macular Edema from the YOSEMITE/RHINE TrialsUsha Chakravarthy, Varun Chaudhary, Srinivas R Sadda, et al.
Ophthalmology. Retina|November 23, 2024
Resolution of Angiographic Macular Leakage with Faricimab versus Aflibercept in Patients with Diabetic Macular Edema in YOSEMITE/RHINERoger A Goldberg, Florie A Mar, Karl Csaky, et al.
Investigative Ophthalmology & Visual Science|May 17, 2024
Intraretinal Hyper-Reflective Foci Are Almost Universally Present and Co-Localize With Intraretinal Fluid in Diabetic Macular EdemaEsther L von Schulthess, Andreas Maunz, Usha Chakravarthy, et al.
Investigative Ophthalmology & Visual Science|August 14, 2025
Author Response: Letter to the Editor Regarding "Intraretinal Hyper-Reflective Foci Are Almost Universally Present and Co-Localize With Intraretinal Fluid in Diabetic Macular Edema"Esther L von Schulthess, Andreas Maunz, Usha Chakravarthy, et al.
Ophthalmology Science|April 30, 2026
Aqueous Humor Biomarkers, Efficacy, and Safety in Patients with Naïve Diabetic Macular Edema Treated with Faricimab: The ALTIMETER StudyPatricio G Schlottmann, Amani A Fawzi, Manuel Amador, et al.
Ophthalmology|January 14, 2026
Four-Year Outcomes of Faricimab in Diabetic Macular Edema: Results From the RHONE-X Extension TrialVeeral S Sheth, Patricio Schlottmann, Timothy Y Y Lai, et al.
Ophthalmology. Retina|February 6, 2025
Anatomic Control with Faricimab versus Aflibercept in the YOSEMITE/RHINE Trials in Diabetic Macular EdemaJennifer I Lim, Manuel J Amador, Dilsher S Dhoot, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Ophthalmology Science|June 11, 2025
Effect of Faricimab versus Aflibercept on Hyperreflective Foci in Patients with Diabetic Macular Edema from the YOSEMITE/RHINE TrialsUsha Chakravarthy, Varun Chaudhary, Srinivas R Sadda, et al.
Ophthalmology. Retina|November 23, 2024
Resolution of Angiographic Macular Leakage with Faricimab versus Aflibercept in Patients with Diabetic Macular Edema in YOSEMITE/RHINERoger A Goldberg, Florie A Mar, Karl Csaky, et al.
Investigative Ophthalmology & Visual Science|May 17, 2024
Intraretinal Hyper-Reflective Foci Are Almost Universally Present and Co-Localize With Intraretinal Fluid in Diabetic Macular EdemaEsther L von Schulthess, Andreas Maunz, Usha Chakravarthy, et al.
Investigative Ophthalmology & Visual Science|August 14, 2025
Author Response: Letter to the Editor Regarding "Intraretinal Hyper-Reflective Foci Are Almost Universally Present and Co-Localize With Intraretinal Fluid in Diabetic Macular Edema"Esther L von Schulthess, Andreas Maunz, Usha Chakravarthy, et al.
Ophthalmology Science|April 30, 2026
Aqueous Humor Biomarkers, Efficacy, and Safety in Patients with Naïve Diabetic Macular Edema Treated with Faricimab: The ALTIMETER StudyPatricio G Schlottmann, Amani A Fawzi, Manuel Amador, et al.
Ophthalmology|January 14, 2026
Four-Year Outcomes of Faricimab in Diabetic Macular Edema: Results From the RHONE-X Extension TrialVeeral S Sheth, Patricio Schlottmann, Timothy Y Y Lai, et al.
Ophthalmology. Retina|February 6, 2025
Anatomic Control with Faricimab versus Aflibercept in the YOSEMITE/RHINE Trials in Diabetic Macular EdemaJennifer I Lim, Manuel J Amador, Dilsher S Dhoot, et al.
Pageof 2